Drug recall
Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial…
FDA recall event 94568 · Class II · PACIRA PHARMACEUTICALS INC
Key facts
| Event ID | 94568 |
|---|---|
| Recall numbers | D-0546-2024 |
| Recalling firm | PACIRA PHARMACEUTICALS INC |
| Product type | Drugs |
| Products | Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC… |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C. |
| Initiation date | May 7, 2024 |
| Report date | Jun 19, 2024 |
| City | San Diego |
| State | CA |
| Country | United States |
| FEI number | 3012265053 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: